Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 12 items for :

  • "somatostatin receptor ligands" x
Clear All
Marta Araujo-Castro Neuroendocrinology Unit, Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Instituto de Investigación Biomédica Ramón y Cajal, Madrid, Spain

Search for other papers by Marta Araujo-Castro in
Google Scholar
PubMed Close
,
Héctor Pian Endocrinology Unit, Department of Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain

Search for other papers by Héctor Pian in
Google Scholar
PubMed Close
,
Ignacio Ruz-Caracuel Endocrinology Unit, Department of Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain

Search for other papers by Ignacio Ruz-Caracuel in
Google Scholar
PubMed Close
,
Alberto Acitores Cancela Neuroendocrinology Unit, Department of Neurosurgery, Hospital Universitario Ramón y Cajal, Madrid, Spain

Search for other papers by Alberto Acitores Cancela in
Google Scholar
PubMed Close
,
Eider Pascual-Corrales Neuroendocrinology Unit, Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Instituto de Investigación Biomédica Ramón y Cajal, Madrid, Spain

Search for other papers by Eider Pascual-Corrales in
Google Scholar
PubMed Close
, and
Víctor Rodríguez Berrocal Neuroendocrinology Unit, Department of Neurosurgery, Hospital Universitario Ramón y Cajal, Madrid, Spain
Endoscopic Skull Base Unit, Department of Neurosurgery, Hospital Universitario HM Puerta del Sur, Madrid, Spain

Search for other papers by Víctor Rodríguez Berrocal in
Google Scholar
PubMed Close

, tumor consistency was reported to be an important predictive factor since hard consistency could impede transsphenoidal resection, especially in macroadenomas ( 8 ). Preoperative somatostatin receptor ligands (SRLs) treatment is proven to reduce GH and

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0414
Volume/Issue:
Volume 10: Issue 1
Open access
Bernardo Maia Neuroendocrinology Research Center/Endocrinology Division – Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Bernardo Maia in
Google Scholar
PubMed Close
,
Leandro Kasuki Neuroendocrinology Research Center/Endocrinology Division – Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Endocrinology Division – Hospital Federal de Bonsucesso, Rio de Janeiro Brazil

Search for other papers by Leandro Kasuki in
Google Scholar
PubMed Close
, and
Mônica R Gadelha Neuroendocrinology Research Center/Endocrinology Division – Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Neuropatology and Molecular Genetics Laboratory – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil

Search for other papers by Mônica R Gadelha in
Google Scholar
PubMed Close

patients have clinical contraindications or refuse to be submitted to surgery ( 4 , 10 ). Currently, there are three classes available for the treatment of acromegaly: somatostatin receptor ligands (SRLs), dopamine agonists, and GH receptor antagonist ( 4

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0433
Volume/Issue:
Volume 9: Issue 12
Open access
Prishila Fookeerah Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, Australia
School of Medicine, Western Sydney University, Sydney, Australia

Search for other papers by Prishila Fookeerah in
Google Scholar
PubMed Close
,
Winny Varikatt Department of Tissue Pathology and Diagnostic Oncology, Westmead Hospital, Sydney, Australia
Westmead Clinical School, University of Sydney, Sydney, Australia

Search for other papers by Winny Varikatt in
Google Scholar
PubMed Close
,
Meena Shingde Department of Tissue Pathology and Diagnostic Oncology, Westmead Hospital, Sydney, Australia
Westmead Clinical School, University of Sydney, Sydney, Australia

Search for other papers by Meena Shingde in
Google Scholar
PubMed Close
,
Mark A J Dexter Westmead Clinical School, University of Sydney, Sydney, Australia
Department of Neurosurgery, Westmead Hospital, Sydney, Australia

Search for other papers by Mark A J Dexter in
Google Scholar
PubMed Close
, and
Mark McLean Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, Australia
School of Medicine, Western Sydney University, Sydney, Australia

Search for other papers by Mark McLean in
Google Scholar
PubMed Close

patient with mild biochemical persistence was treated with a somatostatin receptor ligand (SRL) resulting in normalisation of IGF-1. Of the two residual macrotumours, one was lost to follow-up and the other was managed with SRL with subsequent

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0328
Volume/Issue:
Volume 12: Issue 11
Open access
Peter Wolf Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France
Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Search for other papers by Peter Wolf in
Google Scholar
PubMed Close
,
Alexandre Dormoy Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Alexandre Dormoy in
Google Scholar
PubMed Close
,
Luigi Maione Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Luigi Maione in
Google Scholar
PubMed Close
,
Sylvie Salenave Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Sylvie Salenave in
Google Scholar
PubMed Close
,
Jacques Young Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Jacques Young in
Google Scholar
PubMed Close
,
Peter Kamenický Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Peter Kamenický in
Google Scholar
PubMed Close
, and
Philippe Chanson Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Philippe Chanson in
Google Scholar
PubMed Close

pegvisomant both improve insulin sensitivity ( 6 ), glucose metabolism may improve or worsen when patients are treated with first-generation somatostatin receptor ligands (SRLs), octreotide and lanreotide ( 7 , 8 , 9 , 10 ). Pasireotide is a somatostatin

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0296
Volume/Issue:
Volume 11: Issue 12
Open access
Nelma Veronica Marques Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Nelma Veronica Marques in
Google Scholar
PubMed Close
,
Luiz Eduardo Armondi Wildemberg Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Luiz Eduardo Armondi Wildemberg in
Google Scholar
PubMed Close
, and
Monica R Gadelha Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Monica R Gadelha in
Google Scholar
PubMed Close

Introduction Pasireotide long-acting release is a multireceptor-targeted somatostatin receptor ligand (SRL) approved to treat adult patients with acromegaly ( 1 ). In patients, this second-generation SRL has been shown to be effective in

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0155
Volume/Issue:
Volume 12: Issue 10
Open access
Hélène Lasolle Fédération d’Endocrinologie, Centre de Référence Maladies Rares Hypophysaires HYPO, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France
Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France
INSERM U1052; CNRS UMR5286; Cancer Research Centre of Lyon, Lyon, France

Search for other papers by Hélène Lasolle in
Google Scholar
PubMed Close
,
Amandine Ferriere Service d’endocrinologie, diabète et nutrition, Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France
UFR Sciences médicales, Université de Bordeaux, Bordeaux, France

Search for other papers by Amandine Ferriere in
Google Scholar
PubMed Close
,
Alexandre Vasiljevic Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France
INSERM U1052; CNRS UMR5286; Cancer Research Centre of Lyon, Lyon, France
Centre de Pathologie et de Neuropathologie Est, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France

Search for other papers by Alexandre Vasiljevic in
Google Scholar
PubMed Close
,
Sandrine Eimer UFR Sciences médicales, Université de Bordeaux, Bordeaux, France
Service d’anatomo-pathologie, Hopital Pellegrin, CHU de Bordeaux, Bordeaux, France

Search for other papers by Sandrine Eimer in
Google Scholar
PubMed Close
,
Marie-Laure Nunes Service d’endocrinologie, diabète et nutrition, Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France

Search for other papers by Marie-Laure Nunes in
Google Scholar
PubMed Close
, and
Antoine Tabarin Service d’endocrinologie, diabète et nutrition, Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France
UFR Sciences médicales, Université de Bordeaux, Bordeaux, France

Search for other papers by Antoine Tabarin in
Google Scholar
PubMed Close

acromegaly using current criteria of biochemical ‘cure’ . European Journal of Endocrinology 2005 379 – 387 . ( https://doi.org/10.1530/eje.1.01863 ) 3 Gadelha MR Wildemberg LE Bronstein MD Gatto F Ferone D . Somatostatin receptor ligands in

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0332
Volume/Issue:
Volume 8: Issue 10
Open access
G Giuffrida Endocrine Unit of University Hospital ‘AOU Policlinico G. Martino’, Messina, Italy
PhD School of Clinical and Experimental Biomedical Sciences, University of Messina, Messina, Sicily, Italy

Search for other papers by G Giuffrida in
Google Scholar
PubMed Close
,
F Ferraù Endocrine Unit of University Hospital ‘AOU Policlinico G. Martino’, Messina, Italy
Department of Human Pathology ‘G. Barresi’, University of Messina, Messina, Sicily, Italy

Search for other papers by F Ferraù in
Google Scholar
PubMed Close
,
R Laudicella Nuclear Medicine Unit of University Hospital ‘AOU Policlinico G. Martino’, Messina, Italy
Department of Biomorphology, University of Messina, Messina, Sicily, Italy

Search for other papers by R Laudicella in
Google Scholar
PubMed Close
,
O R Cotta Department of Human Pathology ‘G. Barresi’, University of Messina, Messina, Sicily, Italy

Search for other papers by O R Cotta in
Google Scholar
PubMed Close
,
E Messina Endocrine Unit of University Hospital ‘AOU Policlinico G. Martino’, Messina, Italy

Search for other papers by E Messina in
Google Scholar
PubMed Close
,
F Granata Department of Biomorphology, University of Messina, Messina, Sicily, Italy
Neuroradiology Unit of University Hospital ‘AOU Policlinico G. Martino’, Messina, Italy

Search for other papers by F Granata in
Google Scholar
PubMed Close
,
F F Angileri Department of Biomorphology, University of Messina, Messina, Sicily, Italy
Neurosurgery Unit of University Hospital ‘AOU Policlinico G. Martino’, Messina, Italy

Search for other papers by F F Angileri in
Google Scholar
PubMed Close
,
A Vento Nuclear Medicine Unit of University Hospital ‘AOU Policlinico G. Martino’, Messina, Italy
Department of Biomorphology, University of Messina, Messina, Sicily, Italy

Search for other papers by A Vento in
Google Scholar
PubMed Close
,
A Alibrandi Department of Economics, University of Messina, Messina, Sicily, Italy

Search for other papers by A Alibrandi in
Google Scholar
PubMed Close
,
S Baldari Nuclear Medicine Unit of University Hospital ‘AOU Policlinico G. Martino’, Messina, Italy
Department of Biomorphology, University of Messina, Messina, Sicily, Italy

Search for other papers by S Baldari in
Google Scholar
PubMed Close
, and
S Cannavò Endocrine Unit of University Hospital ‘AOU Policlinico G. Martino’, Messina, Italy
PhD School of Clinical and Experimental Biomedical Sciences, University of Messina, Messina, Sicily, Italy
Department of Human Pathology ‘G. Barresi’, University of Messina, Messina, Sicily, Italy

Search for other papers by S Cannavò in
Google Scholar
PubMed Close

-018-0865-7 ) 29344905 10.1007/s11102-018-0865-7 21 Cuevas-Ramos D Fleseriu M . Somatostatin receptor ligands and resistance to treatment in pituitary adenomas . Journal of Molecular Endocrinology 2014 52 R223 – R240 . ( https://doi.org/10.1530/JME-14-0011 ) 10

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0065
Volume/Issue:
Volume 8: Issue 5
Open access
Adrian F Daly Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Adrian F Daly in
Google Scholar
PubMed Close
,
Liliya Rostomyan Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Liliya Rostomyan in
Google Scholar
PubMed Close
,
Daniela Betea Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Daniela Betea in
Google Scholar
PubMed Close
,
Jean-François Bonneville Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Jean-François Bonneville in
Google Scholar
PubMed Close
,
Chiara Villa Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium
Department of Pathological Cytology and Anatomy, Foch Hospital, Paris, France

Search for other papers by Chiara Villa in
Google Scholar
PubMed Close
,
Natalia S Pellegata Institute for Diabetes and Cancer, Helmholtz Zentrum München, Neuherberg, Germany

Search for other papers by Natalia S Pellegata in
Google Scholar
PubMed Close
,
Beatrice Waser Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Beatrice Waser in
Google Scholar
PubMed Close
,
Jean-Claude Reubi Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Jean-Claude Reubi in
Google Scholar
PubMed Close
,
Catherine Waeber Stephan Clinique Générale Ste-Anne, Fribourg, Switzerland

Search for other papers by Catherine Waeber Stephan in
Google Scholar
PubMed Close
,
Emanuel Christ Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, University of Basel, Basel, Switzerland

Search for other papers by Emanuel Christ in
Google Scholar
PubMed Close
, and
Albert Beckers Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Albert Beckers in
Google Scholar
PubMed Close

Ferone D . Somatostatin receptor ligands in the treatment of acromegaly . Pituitary 2017 20 100 – 108 . ( https://doi.org/10.1007/s11102-017-0791-0 ) 10.1007/s11102-017-0791-0 28176162 17 Körner M Waser B Christ E Beck J Reubi JC . A critical

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0004
Volume/Issue:
Volume 8: Issue 4
Open access
Sylvain Roumeau CHU de Clermont-Ferrand, Service d’Endocrinologie, Diabétologie et Maladies Métaboliques, Clermont-Ferrand, France
Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France

Search for other papers by Sylvain Roumeau in
Google Scholar
PubMed Close
,
Joannice Thevenon CHU Clermont-Ferrand, Service d’Odontologie, Clermont-Ferrand, France

Search for other papers by Joannice Thevenon in
Google Scholar
PubMed Close
,
Lemlih Ouchchane Université Clermont Auvergne, CNRS, ISIT, Clermont-Ferrand, France
CHU Clermont-Ferrand, Service de Biostatistiques, Clermont-Ferrand, France

Search for other papers by Lemlih Ouchchane in
Google Scholar
PubMed Close
,
Salwan Maqdasy Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France
CHU de Clermont-Ferrand, Service d’Endocrinologie, Diabétologie et Maladies Métaboliques, Clermont-Ferrand, France
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France

Search for other papers by Salwan Maqdasy in
Google Scholar
PubMed Close
,
Marie Batisse-Lignier CHU de Clermont-Ferrand, Service d’Endocrinologie, Diabétologie et Maladies Métaboliques, Clermont-Ferrand, France
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France

Search for other papers by Marie Batisse-Lignier in
Google Scholar
PubMed Close
,
Christian Duale Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France
CHU Clermont-Ferrand, Inserm CIC 1405, Clermont-Ferrand, France

Search for other papers by Christian Duale in
Google Scholar
PubMed Close
,
Nathalie Pham Dang Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France
Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France
CHU de Clermont-Ferrand, Service de chirurgie maxillo-faciale, Clermont-Ferrand, France

Search for other papers by Nathalie Pham Dang in
Google Scholar
PubMed Close
,
Philippe Caron CHU Larrey-Rangueil, Service Endocrinologie et Maladies Métaboliques, Pôle Cardio-Vasculaire et Métabolique, Toulouse, France

Search for other papers by Philippe Caron in
Google Scholar
PubMed Close
,
Igor Tauveron CHU de Clermont-Ferrand, Service d’Endocrinologie, Diabétologie et Maladies Métaboliques, Clermont-Ferrand, France
Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France

Search for other papers by Igor Tauveron in
Google Scholar
PubMed Close
, and
Laurent Devoize CHU Clermont-Ferrand, Service d’Odontologie, Clermont-Ferrand, France
Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France
Université Clermont Auvergne, Faculté de Chirurgie Dentaire, Clermont-Ferrand, France

Search for other papers by Laurent Devoize in
Google Scholar
PubMed Close

 Pituitary surgery, n 22  Pituitary radiotherapy, n 5  Medical treatment, n 20    Dopamine agonist, n 7    Somatostatin receptor ligands, n 20    GH receptor antagonist, n 4  Never treated, n 3

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0176
Volume/Issue:
Volume 9: Issue 8
Open access
T L C Wolters Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by T L C Wolters in
Google Scholar
PubMed Close
,
C D C C van der Heijden Division of Experimental Internal Medicine, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Division of Vascular Medicine, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by C D C C van der Heijden in
Google Scholar
PubMed Close
,
N van Leeuwen Department of Physiology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by N van Leeuwen in
Google Scholar
PubMed Close
,
B T P Hijmans-Kersten Department of Physiology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by B T P Hijmans-Kersten in
Google Scholar
PubMed Close
,
M G Netea Division of Experimental Internal Medicine, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by M G Netea in
Google Scholar
PubMed Close
,
J W A Smit Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by J W A Smit in
Google Scholar
PubMed Close
,
D H J Thijssen Department of Physiology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK

Search for other papers by D H J Thijssen in
Google Scholar
PubMed Close
,
A R M M Hermus Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by A R M M Hermus in
Google Scholar
PubMed Close
,
N P Riksen Division of Vascular Medicine, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by N P Riksen in
Google Scholar
PubMed Close
, and
R T Netea-Maier Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by R T Netea-Maier in
Google Scholar
PubMed Close

, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy . Journal of Clinical Endocrinology and Metabolism 2013 1040 – 1050

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0430
Volume/Issue:
Volume 8: Issue 12
Open access